Abbruzzese, James L.

Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus

Hassan, M. M., Hwang, L.-Y., Hatten, C. J., Swaim, M., Li, D., Abbruzzese, J. L., Beasley, P., & Patt, Y. Z. (2002) · Hepatology

Hepatocellular Carcinoma Treatment and PrognosisHepatitis B Virus Studies

Cited by 762

Antidiabetic Therapies Affect Risk of Pancreatic Cancer

Li, D., Yeung, S. J., Hassan, M. M., Konopleva, M., & Abbruzzese, J. L. (2009) · Gastroenterology

Metabolism, Diabetes, and CancerPancreatic and Hepatic Oncology Research

Cited by 584

Diabetes, pancreatogenic diabetes, and pancreatic cancer

Andersen, D. K., Korc, M., Petersen, G. M., Eibl, G., Li, D., Rickels, M. R., Chari, S. T., & Abbruzzese, J. L. (2017) · Diabetes

Pancreatic and Hepatic Oncology ResearchMetabolism, Diabetes, and Cancer

Cited by 516

Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced (T4) Pancreatic Adenocarcinoma: Correlation of Smad4(Dpc4) Immunostaining With Pattern of Disease Progression

Crane, C. H., Varadhachary, G. R., Yordy, J. S., Staerkel, G. A., Javle, M. M., Safran, H., Haque, W., Hobbs, B. D., Krishnan, S., Fleming, J. B., et al. (2011) · Journal of Clinical Oncology

Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment

Cited by 288

Transport properties of pancreatic cancer describe gemcitabine delivery and response

Koay, E. J., Truty, M. J., Cristini, V., Thomas, R. M., Chen, R., Chatterjee, D., Kang, Y., Bhosale, P. R., Tamm, E. P., Crane, C. H., et al. (2014) · Journal of Clinical Investigation

Pancreatic and Hepatic Oncology ResearchMRI in cancer diagnosis

Cited by 184

Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies

Javle, M. M., Shroff, R. T., Xiong, H., Varadhachary, G. A., Fogelman, D., Reddy, S. A., Davis, D., Zhang, Y., Wolff, R. A., & Abbruzzese, J. L. (2010) · BMC Cancer

PI3K/AKT/mTOR signaling in cancerPancreatic and Hepatic Oncology Research

Cited by 170

Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress

Kopetz, S., Lesslie, D. P., Dallas, N. A., Park, S. I., Johnson, M., Parikh, N. U., Kim, M. P., Abbruzzese, J. L., Ellis, L. M., Chandra, J., et al. (2009) · Cancer Research

Colorectal Cancer Treatments and StudiesCancer Mechanisms and Therapy

Cited by 160

A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination

Ramanathan, R. K., Abbruzzese, J., Dragovich, T., Kirkpatrick, L., Guillen, J. M., Baker, A. F., Pestano, L. A., Green, S., & Von Hoff, D. D. (2011) · Cancer Chemotherapy and Pharmacology

Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment

Cited by 122

From Protocols to Publications: A Study in Selective Reporting of Outcomes in Randomized Trials in Oncology

Raghav, K. P. S., Mahajan, S., Yao, J. C., Hobbs, B. P., Berry, D. A., Pentz, R. D., Tam, A., Hong, W. K., Ellis, L. M., Abbruzzese, J., et al. (2015) · Journal of Clinical Oncology

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 59

Hdm2 is regulated by K-Ras and mediates p53-independent functions in pancreatic cancer cells

Sui, X., Shin, S., Zhang, R., Firozi, P. F., Yang, L., Abbruzzese, J. L., & Reddy, S. A. G. (2009) · Oncogene

Cancer-related Molecular PathwaysProtein Kinase Regulation and GTPase Signaling

Cited by 25